ONCOLOGY - Interview of Claire Labreveux, Head of the Unicancer R&D department

Описание к видео ONCOLOGY - Interview of Claire Labreveux, Head of the Unicancer R&D department

My name is Claire Labreveux. I am Head of the Unicancer R&D department. Unicancer is a federation of French comprehensive cancer centers, a network of 20 hospitals dedicated to treating patients with cancer.

To provide patients with earlier detection and ever more innovative and personalized treatments.

We promote clinical studies in more than 200 French and foreign centers and we have established numerous partnerships with companies and international cooperative groups.

Our priorities are to develop research programs to better understand the mechanisms of response to treatment, toxicities and resistance.

We are focused on cancers with poor prognosis, an area neglected by Pharma as rare cancer, elderly population, radiotherapy and so on.

Our goal is really to develop high-quality, practice-changing clinical research and accelerating patients' access to innovation.

France has a solid story in this field. And our experts have
a worldwide reputation and in clinical research, the one done in oncology is leader.

The purpose of these documents is to share research programs, knowledge, training courses, technological innovation and other services, in the field of cancer with as many practitioners, researchers and patients as possible.

------------------------
FRENCH HEALTHCARE is an innovative initiative aimed at bringing together French businesses, researchers and healthcare professionals to jointly promote their innovations, expertise and technologies internationally. It helps promote the French vision for global health, based on a humanist approach to care and equitable and fair access to healthcare products and services.

Follow French Healthcare:
#FrenchHealthcare
Website: https://frenchhealthcare.fr/
Twitter @FrHealthCare_EN:   / frhealthcare_en  
LinkedIn:   / french-healthcare-en  
Youtube:    / @frenchhealthcarexbusinessf828  

Комментарии

Информация по комментариям в разработке